Literature DB >> 11279538

Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells.

Y S Lee1, Y S Kang, S H Lee, J A Kim.   

Abstract

Previously, tamoxifen (TAM) has been shown to induce apoptosis through elevation of intracellular Ca2+ in HepG2 human hepatoblastoma cells. In this study we investigated the role of reactive oxygen species (ROS) in the TAM-induced apoptosis, and interrelationship between intracellular Ca2+ and ROS. TAM induced a slow and sustained increase in intracellular ROS level. An antioxidant, N-acetylcysteine significantly inhibited both ROS production and apoptosis induced by TAM, suggesting that ROS may play an essential role in the TAM-induced apoptosis. In a time frame ROS generation followed intracellular Ca2+ increase, and the extracellular and intracellular Ca2+ chelation with EGTA and BAPTA/AM, respectively, completely inhibited the TAM-induced ROS production, indicating that intracellular Ca2+ may mediate the ROS generation. Inhibitors of NAD(P)H oxidase, diphenylene iodonium, phenylarsine oxide and neopterine, significantly blocked the TAM-induced ROS generation and apoptosis, implying that this oxidase may act as a source enzyme for the production of ROS. These results suggest that non-phagocytic NAD(P)H oxidase may play a novel role as a mediator of the apoptosis associated with intracellular Ca2+ in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11279538     DOI: 10.1038/sj.cdd.4400717

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  13 in total

1.  High-content imaging assays on a miniaturized 3D cell culture platform.

Authors:  Pranav Joshi; Akshata Datar; Kyeong-Nam Yu; Soo-Yeon Kang; Moo-Yeal Lee
Journal:  Toxicol In Vitro       Date:  2018-03-06       Impact factor: 3.500

2.  The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of post-translational regulation.

Authors:  Sebastian Brandt; Hartmut Heller; Klaus-Dieter Schuster; Jürgen Grote
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-16       Impact factor: 4.553

3.  Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

Authors:  Zhen Ren; Si Chen; Ji-Eun Seo; Xiaoqing Guo; Dongying Li; Baitang Ning; Lei Guo
Journal:  Toxicol In Vitro       Date:  2020-08-28       Impact factor: 3.500

4.  Glucuronic acid is a novel inducer of heat shock response.

Authors:  Young Mee Kim; Hee-Jung Kim; Eun Joo Song; Kong-Joo Lee
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

5.  Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic.H2(h4) mice is reactive oxygen species-dependent.

Authors:  R Sharma; K Traore; M A Trush; N R Rose; C Lynne Burek
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

6.  High-Throughput Assessment of Mechanistic Toxicity of Chemicals in Miniaturized 3D Cell Culture.

Authors:  Pranav Joshi; Soo-Yeon Kang; Akshata Datar; Moo-Yeal Lee
Journal:  Curr Protoc Toxicol       Date:  2018-11-02

Review 7.  Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.

Authors:  Meng Xiang; Janet Fan; Jie Fan
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

8.  Tamoxifen reduces fat mass by boosting reactive oxygen species.

Authors:  L Liu; P Zou; L Zheng; L E Linarelli; S Amarell; A Passaro; D Liu; Z Cheng
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

9.  Comparison of cytotoxicity and genotoxicity of 4-hydroxytamoxifen in combination with Tualang honey in MCF-7 and MCF-10A cells.

Authors:  Nik Soriani Yaacob; Nur Faezah Ismail
Journal:  BMC Complement Altern Med       Date:  2014-03-19       Impact factor: 3.659

10.  Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.

Authors:  Raie T Bekele; Ganesh Venkatraman; Rong-Zong Liu; Xiaoyun Tang; Si Mi; Matthew G K Benesch; John R Mackey; Roseline Godbout; Jonathan M Curtis; Todd P W McMullen; David N Brindley
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.